Magnolol attenuates the locomotor impairment, cognitive deficit, and neuroinflammation in Alzheimer’s disease mice with brain insulin resistance via up-regulating miR-200c

In this study, we aimed to investigate the effect of Magnolol on Alzheimer’s disease (AD). After the model of streptozotocin-induced AD mice with brain insulin resistance was established, the mice were treated with Magnolol or miR-200c antagomiR. The abilities of ambulations, rearings, discriminatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ting, Shou, Lan, Guo, Xiaowen, Wei, Mingyang, Zheng, Hui, Tao, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805894/
https://www.ncbi.nlm.nih.gov/pubmed/34968163
http://dx.doi.org/10.1080/21655979.2021.2009975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805894/
https://www.ncbi.nlm.nih.gov/pubmed/34968163
http://dx.doi.org/10.1080/21655979.2021.2009975

Ejemplares similares